Changes of Blood Parameters after Escalating dose with DA-3021 in Cynomolgus Monkey (GENERAL TOXICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
スポンサーリンク
概要
- 論文の詳細を見る
- 日本トキシコロジー学会の論文
- 2003-10-31
著者
-
Han Sang-seop
Korea Institute Of Toxicology
-
CHUNG MOON-KOO
Korea Institute of Toxicology
-
Heo Jeong-doo
Korea Institute Of Toxicology
-
Tarumoto Yasuo
Korea Institute Of Toxicology
-
Kim Choong-Yong
Non-human Primate Team, Toxicology Division, Korea Institute of Toxicology
-
Heo Jeong-Doo
Non-human Primate Team, Toxicology Division, Korea Institute of Toxicology
-
Han Su-Cheol
Non-human Primate Team, Toxicology Division, Korea Institute of Toxicology
-
Jo Yeong-Woo
Research Lab., Dong-A Pharm. Co., Ltd.
-
Tarumoto Yasuo
Non-human Primate Team, Toxicology Division, Korea Institute of Toxicology
-
Chung Moon-Koo
Non-human Primate Team, Toxicology Division, Korea Institute of Toxicology
-
Han Sang-Seop
Non-human Primate Team, Toxicology Division, Korea Institute of Toxicology
-
Jo Yeong-woo
Research Lab. Dong-a Pharm. Co. Ltd.
-
Kim Choong-yong
Non-human Primate Team Toxicology Division Korea Institute Of Toxicology
関連論文
- TOXICITY SCREENING AFTER REPEATED DOSE OF A NEWLY DEVELOPED ORAL HEPARIN DERIVATIVE IN MALE CYNOMOLGUS MONKEYS
- Evaluation of developmental toxicity and placental transfer of the new fluoroquinolone DW-116 in rats (DEVELOPMENT AND REPRODUCTION) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Fine Localization of Nef1 and Nef3 and its Exclusion as Candidate Gene for Lens Rupture 2(Ir2)
- P7-32 Effects of Ketamine hydrochloride on Hematological and Serum Biochemical values in Cynomolgus Monkeys(GENERAL TOXICITY)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Changes of Blood Parameters after Escalating dose with DA-3021 in Cynomolgus Monkey (GENERAL TOXICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Current status of GLP system in Korea.(GENERAL SESSION BY ORAL PRESENTATION)(QUALITY ASSURANCE OF NON-CLINICAL STUDY)